ALB and hepatocellular carcinoma: The clinical features that included assay of direct bilirubin (DBIL), total protein (TP), and albumin (ALB) were significantly different when comparing the HCC and control groups (p < 0.05), in both the discovery panel and the validation panel (Table 1).